NCT00693992
Clinical Trial Information
Trial Number: NCT00693992 (ClinicalTrials.gov)
Disease Type:
- Lung, Mediastinal and Pleural Neoplasm - Non-Small Cell Lung Cancer
Trial Title:
Randomized, Phase III, Double-Blind Placebo-Controlled Trial of Sunitinib (NSC #736511) as Maintenance Therapy in Non-progressing Patients Following an Initial Four Cycles of Platinum-Based Combination Chemotherapy in Advanced, Stage IIIB / IV Non-small Cell Lung Cancer
Study ID:
CALGB-30607
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00693992-D3 | Dataset NCT00693992-D3-Dataset.csv (qol) is one of 3 datasets associated with PubMed ID 28161554. This dataset contains information that will allow you to reproduce the quality of life (qol) analysis. Due to data cleaning efforts, values may contain slight discrepancies from that reported in Table 1 of the Supplemental Materials. |
| NCT00693992-D2 | Dataset NCT00693992-D2-Dataset.csv (toxicity) is one of 3 datasets associated with PubMed ID 28161554. This dataset contains information that will allow you to reproduce the toxicity analysis. |
| NCT00693992-D1 | Dataset NCT00693992-D1-Dataset.csv (clinical) is one of 3 datasets associated with PubMed ID 28161554. This dataset contains information that will allow you to reproduce the baseline characteristics table and primary analysis. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®